About Sterilex
Sterilex Corporation is a recognized leader in developing antimicrobial, anti-biofilm, and decontamination products for infection control, biofilm removal, biodecontamination, and chemical decontamination. Sterilex specialty biofilm-control biocides, disinfectants, and decontamination products are used in a variety of applications including human health, dental health, animal health, food processing, water care, industrial processing, and environmental remediation.

Sterilex patented platform technology is based upon PerQuat™ technology, an alkaline peroxygen phase-transfer chemistry which has the unique ability to penetrate and remove biofilms, kill microorganisms in biofilms, and remove organic contaminants. This chemistry is also effective in decontaminating chemical contaminants including nerve agents, organophosphorus pesticides, and carbamates. The efficacy of Sterilex products is a result of multiple physical and chemical mechanisms of action, including hydrolysis, oxidation, and a physical “scrubbing” effect generated in situ. The combination of physical and chemical mechanisms of action, leading to physical removal of the biofilm as well as killing of resident organisms, reduces the risk of microbial resistance to Sterilex products.

The Sterilex platform PerQuat™ technology is unique in its ability to rapidly penetrate and remove microbial biofilms on surfaces, and to kill microorganisms in biofilms. Microorganisms in biofilms are 1000-times more resistant to antimicrobial attack compared to free-swmming, or planktonic, bacteria. Other antimicrobial chemistries, (most of which were developed prior to the discovery that biofilms are the reservoir for bacteria), are designed to kill free-swimming microorganisms, but are not optimized to attack biofilm bacteria.

Sterilex is a woman-owned firm.